Clinical trial
Comparison of Two Tri-Luma® Maintenance Regimens in the Treatment of Melasma
NCT00500162 · Galderma R&D, Industry · Completed
Key facts
| NCT number | NCT00500162 |
|---|---|
| Title | Comparison of Two Tri-Luma® Maintenance Regimens in the Treatment of Melasma |
| Official title | Comparison of Two Tri-Luma® Maintenance Regimens in the Treatment of Melasma |
| Acronym | CLARA |
| Lead sponsor | Galderma R&D, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Melasma |
| Intervention type | Behavioral |
| Interventions | Tri-Luma Maintenance regimen |
| Enrollment | 340 |
| Start date | Nov 1, 2006 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Jul 12, 2007 |
| Last update posted | Feb 17, 2021 |
| Countries | Brazil, Mexico |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: